Streamex (NASDAQ: STEX) a technology company focused on commodity market tokenization, announced that Chief Financial Officer Christine Plummer will present at the ThinkEquity Conference on Oct. 15, 2026, at the Mandarin Oriental Hotel in New York City. The presentation is scheduled for 4 p.m. ET and will be available via live webcast on the company’s […]

Many blockchain ecosystems rely heavily on token issuance and community funding to support development. A project issues a token, sells some of it and hopes enough demand develops to support the ecosystem as products and services are built. While that model has helped fund blockchain projects, it can also create challenges when token prices decline […]

Greenland Mines (NASDAQ: GRML; FSE: HK6) was featured in a HotCopper article examining its expanding critical minerals portfolio in Greenland. The article highlights the company’s Skaergaard palladium-gold-platinum project and its recently acquired Sarfartoq rare earths project, which focuses on neodymium and praseodymium. It also details the company’s 2026 technical progress, including drilling, bulk sampling and […]

Nutriband (NASDAQ: NTRB) announced that it has filed a non-provisional utility patent application with the U.S. Patent and Trademark Office to strengthen intellectual property protection for its AVERSA (TM) abuse-deterrent transdermal technology. The application covers improved aversive formulations and coating methods designed to enhance the technology’s abuse-deterrent properties. If granted, the patent could extend protection […]

The growing interest in telerobotic surgery is putting SS Innovations International (NASDAQ: SSII) and its founder and CEO, cardiac surgeon Dr. Sudhir Srivastava, in an increasingly relevant part of the surgical robotics market. A recent MedTech Dive report, “Telerobotic surgery is advancing around the world. Will the US embrace it?,” examined the technology’s development and […]

VERAXA Biotech (NASDAQ: VRXA), a developer of next-generation antibody-based cancer therapies, provided an update on its strategy to implement U.S. Food and Drug Administration “FDA”-aligned New Approach Methodologies “NAMs” across its preclinical research and development programs. The company said the approach could accelerate clinical advancement, reduce development costs and timelines and significantly reduce animal testing. […]

Mobilicom (NASDAQ: MOB) , a provider of cybersecure solutions for drones and robotics, announced its participation in the Association of the United States Army “AUSA” 2026 Annual Meeting & Exposition, taking place Oct. 12-14 in Washington, D.C., and the ThinkEquity Conference on Oct. 15 in New York. At AUSA, Mobilicom will showcase its portfolio of […]

Most multiple sclerosis (“MS”) drugs work by quieting the immune system. A new partnership shines the spotlight on a different approach — protecting the nerve’s own insulation — and sets up that treatment for a rigorous clinical test. Quantum BioPharma (NASDAQ: QNTM), a biopharmaceutical company developing therapies for neurodegenerative and metabolic disorders, has signed a […]

Beeline Holdings (NASDAQ: BLNE), a digital mortgage platform, will host a stakeholder update call on its third-quarter 2026 results on Thursday, Nov. 12, at 5 p.m. ET. CEO Nick Liuzza and CFO Chris Moe will review the company’s performance and provide updates on ongoing initiatives. To view the full press release, visit https://ibn.fm/Tvaul About Beeline […]

Blockchain adoption has increasingly moved beyond the question of whether businesses can use digital assets. The more important question is what infrastructure can support those applications as they become more complex and specialized. That is where MindWave Innovations (NYSE American: APUS) is positioning its business. Rather than building around a single application or token, MindWave’s […]

Quantum BioPharma (NASDAQ: QNTM) entered into a Study Start-Up Agreement (“SUA”) with the clinical research business of Thermo Fisher Scientific to implement its Phase 2 clinical trial of Lucid-21-302 (“Lucid-MS”) for multiple sclerosis (“MS”). The agreement initiates formal study start-up activities following FDA clearance to proceed with the trial. Thermo Fisher will support study start-up […]

Beeline Holdings (NASDAQ: BLNE) provided a preliminary update on third-quarter 2026 performance, expecting revenue to reach the second-highest quarterly level in company history and the highest since 2021, while achieving its highest margins to date. Beeline also expects its net loss to decline from Q2, adjusted EBITDA loss to improve to its lowest level in […]